Showing results (751-760 of 772) with videos related to

Sort By:
Pageof 78
The Journal of Biological Chemistry|January 2, 2007
Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptorCatherine M Radcliffe, James N Arnold, David M Suter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 10, 2010
Longer-term assessment of trastuzumab-related cardiac adverse events in the Herceptin Adjuvant (HERA) trialMarion Procter, Thomas M Suter, Evandro de Azambuja, et al.
Cell Metabolism|January 11, 2018
Extracellular Vesicles Provide a Means for Tissue Crosstalk during ExerciseMartin Whitham, Benjamin L Parker, Martin Friedrichsen, et al.
JCI Insight|July 31, 2020
Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonistFrancis S Willard, Jonathan D Douros, Maria Bn Gabe, et al.
Endocrinology|September 23, 2017
Regulation of Endogenous (Male) Rodent GLP-1 Secretion and Human Islet Insulin Secretion by Antagonism of Somatostatin Receptor 5Thomas B Farb, Marta Adeva, Thomas J Beauchamp, et al.
The Lancet. Oncology|August 13, 2013
Adjuvant bevacizumab-containing therapy in triple-negative breast cancer (BEATRICE): primary results of a randomised, phase 3 trialDavid Cameron, Julia Brown, Rebecca Dent, et al.
Journal of Thrombosis and Haemostasis : JTH|September 2, 2024
Biomarker-enhanced cardiovascular risk prediction in patients with cancer: a prospective cohort studySimon Kraler, Luca Liberale, Stephan Nopp, et al.
Ecancermedicalscience|June 17, 2014
Report on the international colloquium on cardio-oncology (rome, 12-14 march 2014)Michael Ewer, Luca Gianni, Fabrizio Pane, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 25, 2022
Structural determinants of dual incretin receptor agonism by tirzepatideBingfa Sun, Francis S Willard, Dan Feng, et al.
Lancet (London, England)|January 31, 2026
Prediction of mortality, bleeding, and ischaemic events in patients with cancer and acute coronary syndrome: a model development and validation studyFlorian A Wenzl, Kok Weng Ow, Matthijs A Velders, et al.
Pageof 78